The strategic partnership will also support the WHO resolution WHA78.13 with the aim to improve access to medical imaging and nuclear medicine February 25, 2026 -- Wiesbaden, Germany. The ...

A novel quantitative PET- and MRI-based imaging approach can objectively identify a recently recognized type of dementia--limbic-predominant age-related TDP-43 encephalopathy, or LATE--that is often ...

A novel nuclear medicine imaging protocol can take the place of two separate imaging scans for the evaluation of brain changes linked to cognitive impairment, cutting costs and radiation exposure for ...

The use of marijuana and new weight loss pharmaceuticals can have an impact on gastric emptying scans commonly used to evaluate patients with gastrointestinal complaints. With the increased usage of ...

Reston, VA (November 1, 2024)—The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is celebrating a landmark victory for patients and care providers as the Centers for Medicare & Medicaid ...

A novel quantitative PET- and MRI-based imaging approach can objectively identify a recently recognized type of dementia—limbic-predominant age-related TDP-43 encephalopathy, or LATE—that is often ...

Reston, VA—A new study has determined that approximately three percent of all bone scan patients have markers of cardiac amyloidosis, which can lead to heart failure and increased mortality. Published ...

Participants attend the Ministry of Health’s international workshop on the latest developments in nuclear medicine and molecular imaging for diagnosing neurological diseases ...

Doctors have used radioiodine therapy, a type of nuclear medicine treatment, since the 1940s. Now, a new generation of radiopharmaceuticals offers expanded treatment options for people with some types ...

This nuclear medicine market report forecasts global industry size to reach USD 35.32 Bn by 2031 as therapeutic radiopharmaceuticals grow further and adoption of targeted radiotherapy increases.